TXNIP and liver dysplastic nodule: TXNIP inhibitor (ruscogenin) promoted the effects of Schisandrin A on glomerulus injury, blood glucose, body weight, kidney/body weight, serum creatinine, urea nitrogen, urinary albumin levels, and inflammation factors release in mice with DN (Figures 6(e)–6(o)).